Citrus extracts, particularly bergamot essential oil (BEO) and its fractions, have been found to exhibit
anticancer efficacy. However, the poor water solubility, low stability and limited bioavailability have
prevented the use of BEO in cancer therapy. To overcome such drawbacks, we formulated BEO liposomes
that improved the water solubility of the phytocomponents and increased their anticancer activity in vitro
against human SH-SY5Y neuroblastoma cells. The results warrant further investigation of BEO liposomes
for in vivo applications.